AtriCure: BlackRock reports 15.4% ownership stake
BlackRock reports sole voting power over 7,763,851 shares and sole dispositive power over 7,837,484 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AtriCure, Inc. (ATRC) is the issuer in BlackRock, Inc.'s report of beneficial ownership of 7,837,484 common shares, or 15.4% of the class. BlackRock reports sole voting power over 7,763,851 shares and sole dispositive power over 7,837,484 shares, with 0 shared voting power and 0 shared dispositive power. The report identifies iShares Core S&P Small-Cap ETF as having an interest in more than 5% of AtriCure's total outstanding common stock.
Key Figures
Key Terms
beneficially owned financial
sole power to vote financial
sole power to dispose financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which fund has an interest in more than 5% of ATRC?
AI-generated analysis. How Rhea-AI works. Not financial advice.